Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 161346, 10 pages
http://dx.doi.org/10.1155/2014/161346
Research Article

Molecular Mechanisms of Curcumin on Diabetes-Induced Endothelial Dysfunctions: Txnip, ICAM-1, and NOX2 Expressions

1Center of Excellence for Microcirculation, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
2Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

Received 4 March 2014; Revised 4 June 2014; Accepted 8 June 2014; Published 26 June 2014

Academic Editor: George Perry

Copyright © 2014 Natchaya Wongeakin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Fatehi-Hassanabad, C. B. Chan, and B. L. Furman, “Reactive oxygen species and endothelial function in diabetes,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 8–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Perez-Matute, M. A. Zulet, and J. A. Martinez, “Reactive species and diabetes: counteracting oxidative stress to improve health,” Current Opinion in Pharmacology, vol. 9, no. 6, pp. 771–779, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Soldatos and M. E. Cooper, “Diabetic nephropathy: important pathophysiologic mechanisms,” Diabetes Research and Clinical Practice, vol. 82, supplement 1, pp. S75–S79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, part 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. P. C. Schulze, H. Liu, E. Choe et al., “Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2666–2672, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. C. Schulze, J. Yoshioka, T. Takahashi, Z. He, G. L. King, and R. T. Lee, “Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein,” The Journal of Biological Chemistry, vol. 279, no. 29, pp. 30369–30374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Li, Y. Rong, M. Zhang et al., “Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells,” Biochemical and Biophysical Research Communications, vol. 381, no. 4, pp. 660–665, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Cha-Molstad, G. Saxena, J. Chen, and A. Shalev, “Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells,” The Journal of Biological Chemistry, vol. 284, no. 25, pp. 16898–16905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Nishiyama, M. Matsui, S. Iwata et al., “Identification of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression,” Journal of Biological Chemistry, vol. 274, no. 31, pp. 21645–21650, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Junn, S. H. Han, J. Y. Im et al., “Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function,” Journal of Immunology, vol. 164, no. 12, pp. 6287–6295, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. O. N. Spindel, C. World, and B. C. Berk, “Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms,” Antioxidants & Redox Signaling, vol. 16, no. 6, pp. 587–596, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. C. B. Harrison, G. R. Drummond, C. G. Sobey, and S. Selemidis, “Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice,” Clinical and Experimental Pharmacology and Physiology, vol. 37, no. 4, pp. 429–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Yamawaki and B. C. Berk, “Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels,” Current Opinion in Nephrology & Hypertension, vol. 14, no. 2, pp. 149–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Yamawaki, S. Pan, R. T. Lee, and B. C. Berk, “Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 733–738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Perrone, T. S. Devi, K. Hosoya, T. Terasaki, and L. P. Singh, “Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions,” Journal of Cellular Physiology, vol. 221, no. 1, pp. 262–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Perrone, T. S. Devi, K. I. Hosoya, T. Terasaki, and L. P. Singh, “Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy,” Cell Death & Disease, vol. 1, no. 8, article e65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Szabo, M. T. Droy-Lefaix, M. Doly, and P. Braquet, “Free radical-mediated effects in reperfusion injury: a histologic study with superoxide dismutase and EGB 761 in rat retina,” Ophthalmic Research, vol. 23, no. 4, pp. 225–234, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Omori, T. Ohira, Y. Uchida et al., “Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase,” Journal of Leukocyte Biology, vol. 84, no. 1, pp. 292–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Al-Shabrawey, M. Rojas, T. Sanders et al., “Role of NADPH oxidase in retinal vascular inflammation,” Investigative Ophthalmology & Visual Science, vol. 49, no. 7, pp. 3239–3244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. K. Jain, J. Rains, and K. Jones, “Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels,” Free Radical Biology & Medicine, vol. 41, no. 1, pp. 92–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Kowluru and M. Kanwar, “Effects of curcumin on retinal oxidative stress and inflammation in diabetes,” Nutrition and Metabolism, vol. 4, article 8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Meghana, G. Sanjeev, and B. Ramesh, “Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role,” European Journal of Pharmacology, vol. 577, no. 1–3, pp. 183–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Kanitkar and R. R. Bhonde, “Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme oxygenase-1, during cryopreservation,” Life Sciences, vol. 82, no. 3-4, pp. 182–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. N. A. Mandal, J. M. R. Patlolla, L. Zheng et al., “Curcumin protects retinal cells from light-and oxidant stress-induced cell death,” Free Radical Biology & Medicine, vol. 46, no. 5, pp. 672–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. K.-A. Jung and M.-K. Kwak, “The Nrf2 system as a potential target for the development of indirect antioxidants,” Molecules, vol. 15, no. 10, pp. 7266–7291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Molina-Jijón, E. Tapia, C. Zazueta et al., “Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway,” Free Radical Biology and Medicine, vol. 51, no. 8, pp. 1543–1557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Gao, J. Kuo, H. Jiang et al., “Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro,” Biochemical Pharmacology, vol. 68, no. 1, pp. 51–61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. G. Binion, J. Heidemann, M. S. Li, V. M. Nelson, M. F. Otterson, and P. Rafiee, “Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF- κB: inhibitory role of curcumin,” American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 297, no. 2, pp. G259–G268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Deeb, H. Jiang, X. Gao et al., “Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-κB via inhibition of the prosurvival Akt signaling pathway,” The Journal of Pharmacology and Experimental Therapeutics, vol. 321, no. 2, pp. 616–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Banerjee, L. M. Tripathi, V. M. L. Srivastava, A. Puri, and R. Shukla, “Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat,” Immunopharmacology and Immunotoxicology, vol. 25, no. 2, pp. 213–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Kumar, S. Dhawan, N. J. Hardegen, and B. B. Aggarwal, “Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)- mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-κB activation,” Biochemical Pharmacology, vol. 55, no. 6, pp. 775–783, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Gupta and B. Ghosh, “Curcuma longa inhibits TNF-α induced expression of adhesion molecules on human umbilical vein endothelial cells,” International Journal of Immunopharmacology, vol. 21, no. 11, pp. 745–757, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Patumraj, N. Wongeakin, P. Sridulyakul, A. Jariyapongskul, N. Futrakul, and S. Bunnag, “Combined effects of curcumin and vitamin C to protect endothelial dysfunction in the iris tissue of STZ-induced diabetic rats,” Clinical Hemorheology and Microcirculation, vol. 35, no. 4, pp. 481–489, 2006. View at Google Scholar · View at Scopus
  34. N. Wongeakin, P. Sridulyakul, A. Jariyapongskul, N. Futrakula, S. C. Bunnag, and S. Patumraj, “Effects of curcumin and tetrahydrocurcumin on stz-induced diabetic rats,” Journal of Vascular Research, vol. 43, p. 32, 2006. View at Google Scholar
  35. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 34, supplement 1, pp. S62–S69, 2011. View at Publisher · View at Google Scholar
  36. F. Bandello, R. Brancato, R. Lattanzio, M. Galdini, and B. Falcomata, “Relation between iridopathy and retinopathy in diabetes,” British Journal of Ophthalmology, vol. 78, no. 7, pp. 542–545, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Jariyapongskul, T. Rungjaroen, N. Kasetsuwan, S. Patumraj, J. Seki, and H. Niimi, “Long-term effects of oral vitamin C supplementation on the endothelial dysfunction in the iris microvessels of diabetic rats,” Microvascular Research, vol. 74, no. 1, pp. 32–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Stuehmer, P. Schumann, K. Bormann et al., “A new model for chronic in vivo analysis of the periosteal microcirculation,” Microvascular Research, vol. 77, no. 2, pp. 104–108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. K. Saetzler, J. Jallo, H. A. Lehr et al., “Intravital fluorescence microscopy: impact of light-induced phototoxicity on adhesion of fluorescently labeled leukocytes,” Journal of Histochemistry and Cytochemistry, vol. 45, no. 4, pp. 505–513, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Byfield, S. Budd, and M. E. Hartnett, “The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model,” Investigative Ophthalmology & Visual Science, vol. 50, no. 7, pp. 3360–3365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Trichonas, A. Manola, Y. Morizane et al., “A novel nonradioactive method to evaluate vascular barrier breakdown and leakage,” Investigative Ophthalmology & Visual Science, vol. 51, no. 3, pp. 1677–1682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Chen, J. Zhang, Y. Zhang, Y. Wang, and B. Wang, “Improvement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats,” Inflammation Research, vol. 57, no. 5, pp. 199–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Shelev, “Lack of TXNIP protects β-cells against glucotoxicity,” Biochemical Society Transactions, vol. 36, part 5, pp. 963–965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Rungseesantivanon, N. Thenchaisri, P. Ruangvejvorachai, and S. Patumraj, “Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition,” BMC Complementary and Alternative Medicine, vol. 10, article 57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Rungseesantivanon, N. Thengchaisri, P. Ruangvejvorachai, and S. Patumraj, “Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-kappaB suppression,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 3, pp. 421–429, 2010. View at Google Scholar
  47. K. Seo, M. Choi, U. J. Jung et al., “Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice,” Molecular Nutrition and Food Research, vol. 52, no. 9, pp. 995–1004, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy, “Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats,” Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 2092–2099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Chanpoo, H. Petchpiboonthai, B. Panyarachun, and V. Anupunpisit, “Effect of curcumin in the amelioration of pancreatic islets in streptozotocin-induced diabetic mice,” Journal of the Medical Association of Thailand, vol. 93, supplement 6, pp. S152–S159, 2010. View at Google Scholar · View at Scopus
  50. S. M. Nam, M. Y. Lee, J. H. Koh et al., “Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property,” Diabetes Research and Clinical Practice, vol. 83, no. 2, pp. 176–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Awasthi, S. Tota, K. Hanif, C. Nath, and R. Shukla, “Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow,” Life Sciences, vol. 86, no. 3-4, pp. 87–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. K. Gupta, B. Kumar, T. C. Nag et al., “Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 2, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. V. P. Menon and A. R. Sudheer, “Antioxidant and anti-inflammatory properties of curcumin,” Advances in Experimental Medicine and Biology, vol. 595, pp. 105–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Pemp and L. Schmetterer, “Ocular blood flow in diabetes and age-related macular degeneration,” Canadian Journal of Ophthalmology, vol. 43, no. 3, pp. 295–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B. B. Aggarwal, and Y. Kondo, “Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of akt and extracellular signal-regulated kinase signaling pathways,” Molecular Pharmacology, vol. 72, no. 1, pp. 29–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Yang, P. H. Lane, J. S. Pollock, and P. K. Carmines, “Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb,” Hypertension, vol. 55, no. 2, pp. 468–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Asaba, A. Tojo, M. L. Onozato et al., “Effects of NADPH oxidase inhibitor in diabetic nephropathy,” Kidney International, vol. 67, no. 5, pp. 1890–1898, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. K. H. Tsai, W. J. Wang, C. W. Lin et al., “NADPH oxidase-derived superoxide Anion-induced apoptosis is mediated via the JNK-dependent activation of NF-κB in cardiomyocytes exposed to high glucose,” Journal of Cellular Physiology, vol. 227, no. 4, pp. 1347–1357, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Szabó, A. Farkas, R. Vámos, T. Bajor, and A. Hrabák, “The inhibition of retinal inducible nitric oxide synthase overexpression and the attenuation of experimental uveitis by anti-inflammatory drugs in rats,” Inflammation Research, vol. 53, no. 6, pp. 262–267, 2004. View at Publisher · View at Google Scholar · View at Scopus